ClearPoint Neuro Inc (NASDAQ: CLPT) started the day on Wednesday, with a price increase of 58.55% at $19.28, before settling in for the price of $12.16 at the close. Taking a more long-term approach, CLPT posted a 52-week range of $9.76-$19.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of -10.69% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -10.69%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -15.00%. This publicly-traded company’s shares outstanding now amounts to $28.42 million, simultaneously with a float of $24.34 million. The organization now has a market capitalization sitting at $548.08 million. At the time of writing, stock’s 50-day Moving Average stood at $11.06, while the 200-day Moving Average is $13.30.
ClearPoint Neuro Inc (CLPT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. ClearPoint Neuro Inc’s current insider ownership accounts for 14.39%, in contrast to 33.53% institutional ownership. According to the most recent insider trade that took place on Jun 10 ’25, this organization’s Director sold 10,000 shares at the rate of 13.28, making the entire transaction reach 132,800 in total value, affecting insider ownership by 77,381. Preceding that transaction, on Jun 09 ’25, Company’s CEO and President sold 21,247 for 13.29, making the whole transaction’s value amount to 282,373. This particular insider is now the holder of 243,522 in total.
ClearPoint Neuro Inc (CLPT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
ClearPoint Neuro Inc’s EPS decrease for this current 12-month fiscal period is -15.00% and is forecasted to reach -0.68 in the upcoming year.
ClearPoint Neuro Inc (NASDAQ: CLPT) Trading Performance Indicators
Let’s observe the current performance indicators for ClearPoint Neuro Inc (CLPT). It’s Quick Ratio in the last reported quarter now stands at 6.45. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.32.
In the same vein, CLPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.80, a figure that is expected to reach -0.20 in the next quarter, and analysts are predicting that it will be -0.68 at the market close of one year from today.
Technical Analysis of ClearPoint Neuro Inc (CLPT)
If we take a close look at the recent performances of ClearPoint Neuro Inc (NASDAQ: CLPT), its last 5-days Average volume was 2.81 million that shows progress from its year to date volume of 0.38 million. During the previous 9 days, stock’s Stochastic %D was recorded 82.41% While, its Average True Range was 92.66.
Raw Stochastic average of ClearPoint Neuro Inc (CLPT) in the period of the previous 100 days is set at 84.91%, which indicates a major rise in contrast to 84.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.91 that was higher than 0.68 volatility it exhibited in the past 100-days period.
